Gladius Capital Management LP Abbott Laboratories Transaction History

Gladius Capital Management LP

$166 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$100.73 - $112.44 $221,505 - $247,255	-2,199 Reduced 36.25%	3,867 $401,000
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $664,348 - $733,743	6,066 New	6,066 $689,000
Q3 2023 Dec 18, 2023	BUY	$95.53 - $114.62 $1.04 Million - $1.24 Million	10,837 Added 1149.2%	11,780 $1.14 Million
Q3 2023 Oct 10, 2023	BUY	$95.53 - $114.62 $1.04 Million - $1.24 Million	10,837 Added 1149.2%	11,780 $1.14 Million
Q2 2023 Dec 18, 2023	SELL	$100.78 - $112.29 $1.09 Million - $1.22 Million	-10,837 Reduced 91.99%	943 $102,000
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $1.86 Million - $2.08 Million	-18,483 Reduced 95.15%	943 $103,000
Q1 2023 Dec 18, 2023	BUY	$96.86 - $114.01 $740,591 - $871,720	7,646 Added 64.91%	19,426 $1.97 Million
Q1 2023 May 09, 2023	BUY	$96.86 - $114.01 $1.67 Million - $1.96 Million	17,194 Added 770.34%	19,426 $1.97 Million
Q4 2022 Dec 18, 2023	SELL	$95.06 - $111.52 $907,632 - $1.06 Million	-9,548 Reduced 81.05%	2,232 $245,000
Q4 2022 Feb 02, 2023	SELL	$95.06 - $111.52 $1.19 Million - $1.39 Million	-12,488 Reduced 84.84%	2,232 $246,000
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $1.07 Million - $1.24 Million	11,094 Added 305.96%	14,720 $1.43 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $254,970 - $308,178	2,498 Added 221.45%	3,626 $394,000
Q1 2022 Apr 29, 2022	BUY	$114.02 - $139.04 $92,698 - $113,039	813 Added 258.1%	1,128 $134,000
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $36,391 - $44,559	315 New	315 $45,000
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $91,316 - $107,584	-839 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $10,290 - $11,213	98 Added 13.23%	839 $92,000
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $67,905 - $82,465	741 New	741 $81,000
Q2 2020 Aug 07, 2020	SELL	$76.57 - $98.0 $428,409 - $548,310	-5,595 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$62.82 - $91.86 $263,404 - $385,168	4,193 Added 299.07%	5,595 $442,000
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $186,775 - $207,924	-2,379 Reduced 62.92%	1,402 $122,000
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $309,437 - $335,525	3,781 New	3,781 $317,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.5 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.05 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.76 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.29 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Gladius Capital Management LP with notifications on news.

Account